TITLE

Federal Advisory Committees, Policy Expertise, and the Approval of Drugs and Medical Devices at the FDA

AUTHOR(S)
Lavertu, Stéphane; Weimer, David L.
PUB. DATE
April 2011
SOURCE
Journal of Public Administration Research & Theory;Apr2011, Vol. 21 Issue 2, p211
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study from the Journal of Public Administration Research and Theory which examines the influence of federal advisory committees on the decision of Food and Drug Administration (FDA) to approve or not the pharmaceutical drugs and medical devices for marketing in the U.S. The influence of committee advice on FDA decision making were estimated by the researchers using the 1997-2006 drug and device approval data. The study finds out that there is an increase in the probability of FDA approval due to increase in the proportion of committee members who vote for drug approval. The study also notes that the increase in the proportion of committee members voting for approval lessens the time it takes for the FDA to agree a drug or device application after consultation.
ACCESSION #
59688595

 

Related Articles

  • The Food and Drug Administration Advisory Committees and Panels: How They Are Applied to the Drug Regulatory Process. Ciociola, Arthur A; Karlstadt, Robyn G; Pambianco, Daniel J; Woods, Karen L; Ehrenpreis, Eli D // American Journal of Gastroenterology;Oct2014, Vol. 109 Issue 10, p1508 

    Food and Drug Administration (FDA) advisory panels and committees play a critical role in advising the FDA on the safety and efficacy of medical devices and drugs marketed in the US. Advisory panel recommendations are used by the FDA to make decisions regarding medical products. Currently, the...

  • Device approval exposes political pressure on FDA.  // Indianapolis Business Journal;10/12/2009, Vol. 30 Issue 32, p17 

    The article reports on the political pressure put by the U.S. government towards its approval of a knee pair device, which rejected by the Food and Drug Administration (FDA) in 2008. FDA officials has called the situation as an anomaly, but experts said that there is nothing to stop political...

  • A Panoply Of Product Approvals. Nordenberg, Tamar // FDA Consumer;May/Jun2000, Vol. 34 Issue 3, p10 

    Presents a list of drugs and medical devices approved for marketing by the United States Food and Drug Administration. Product Name; Classification of diseases the drugs are used; Sponsors.

  • FDA Issues Assessments of the 510(k) Program and Use of Science in Decision-Making Recommendations focus on innovation, regulatory predictability, and patient safety.  // Biomedical Market Newsletter;12/20/2010, p210 

    The article reports that the U.S. Food and Drug Administration (FDA) has issued Assessments of the 510(k) Program and Use of Science in Decision-Making. FDA issued two comprehensive evaluations that recommend fostering device innovation, creating a more predictable regulatory environment, and...

  • Avian flu news may have flown the coop, but risks are still real.  // Drug Store News;6/25/2007, Vol. 29 Issue 8, p94 

    The article reports that U.S. government has been preparing for a possible avian flu pandemic while the flu news has been settled. The Food and Drug Administration has cleared for marketing the first respirators that can help reduce the user's exposure to airborne germs during a public health...

  • Using Evidence-Based Medicine to Select Wound Care Products. Aung, Barbara J. // Podiatry Management;Nov/Dec2007, Vol. 26 Issue 9, p213 

    The article offers suggestions on making informed decisions on selecting evidence-based wound care products. Medical devices are classified by the U.S. Food and Drug Administration (FDA) into General Controls, Special Controls and Premarket Approval (PMA) or Humanitarian Device Exemption. It...

  • Guidance for site monitoring eases hand-off to contractors. McCARTY, MARK // Medical Device Daily;8/8/2013, Vol. 17 Issue 152, p1 

    This section offers news briefs on U.S. policies concerning the medical technology sector as of August 8, 2013. The guidance on clinical trial site monitoring, a document aimed at dealing with modern capabilities for data transfer as well as the various levels of risk linked with clinical...

  • Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study. Li-Chia Chen; Darren Ashcroft; Rachel Elliott // Pharmacy World & Science;Dec2007, Vol. 29 Issue 6, p661 

    Abstract Objective  To explore pharmacists’ perceptions on the use of economic evaluations in decision-making within Medicine Management Committees (MMCs), identify factors that influence the uptake of economic evidence and examine the usefulness of different...

  • FDA Drug Approvals.  // Formulary;Jan2001, Vol. 36 Issue 1, p9 

    Introduces drugs approved by the United States Food and Drug Administration (FDA). Use of Azelastine HCL in treating symptoms of vasomotor rhinitis; Application of Enoxaparin sodium for prophylaxis of deep vein thrombosis; Efficacy of Neurontin, an antiepileptic drug.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics